JENLiFE is a specialized company developing next-generation electronic nose technology based on the M13 bacteriophage, a material similar to human olfactory receptors.

By utilizing M13 bacteriophages as olfactory receptors, the company has developed high-performance electronic noses capable of detecting a wide range of volatile organic compounds (VOCs) with high sensitivity.

In addition, JENLiFE develops precision analytical instruments such as liquid substance detectors and colorimeters using its proprietary core technology.

Through disease diagnosis research, JENLiFE has established technological capabilities that span the entire process?from materials, sensors, and signal processing to AI and clinical studies?allowing for integrated design and implementation.

The company’s technology is applied not only in disease diagnosis, such as lung cancer and oral diseases, but also across diverse industrial fields, including water quality monitoring and compost maturity assessment.

This equipment performs RGB change and RGB speed analysis of the sample and is capable of real-time multi-channel (96) simultaneous measurement.

Data reliability was ensured by applying internal chamber temperature and humidity monitoring, ventilation, and air cooling systems.